Skip to main content

Table 2 Sensitivity and specificity of Borrelia multiplex against a commercial 2-step diagnostics

From: Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies

Classification

Sensitivity

Specificity

Manual processing

Automated processing

Manual processing

Automated processing

IgG + IgM

2-Step testing positive: 42

Borrelia multiplex: positive consensus: 40

Sens.: 95.2% (84.2–99.2%)

PPV: 47.6%

2-Step testing positive: 42

Borrelia multiplex: positive consensus: 36

Sens.: 85.7% (72.2–93.3%)

PPV: 53.7%

2-Step testing negative: 620

Borrelia multiplex: negative consensus: 576

Spec.: 93.0% (90.6–94.7%)

NPV: 99.7%

2-Step testing negative: 620

Borrelia multiplex: negative consensus: 589

Spec.: 95.0% (93.0–96.5%)

NPV: 99.0%

IgG

2-Step testing positive: 39

Borrelia multiplex: positive consensus: 37

Sens.: 94.9% (83.1–99.1%)

PPV: 80.4%

2-Step testing positive: 39

Borrelia multiplex: positive consensus: 32

Sens.: 82.1% (67.3–91.0%)

PPV: 80.0%

2-Step testing negative: 623

Borrelia multiplex: negative consensus: 614

Spec.: 98.6% (97.3–99.2%)

NPV: 99.7%

2-Step testing negative: 623

Borrelia multiplex: negative consensus: 615

Spec.: 98.7% (97.5–99.3%)

NPV: 98.9%

IgM

2-Step testing positive: 7

Borrelia multiplex: positive consensus: 5

Sens.: 71.4% (35.9–94.9%)

PPV: 11.6%

2-Step testing positive: 7

Borrelia multiplex: positive consensus: 5

Sens.: 71.4% (35.9–94.9%)

PPV: 17.2%

2-Step testing negative: 655

Borrelia multiplex: negative consensus: 617

Spec.: 94.2% (92.1–95.7%)

NPV: 99.7%

2-Step testing negative: 655

Borrelia multiplex: negative consensus: 631

Spec.: 96.3% (94.6–97.5%)

NPV: 99.7%

  1. Sensitivity and specificity were determined based on a comparison with a 2-step diagnostics consisting of an ELISA and an immunoblot (both Virotech Diagnostics). The determination was carried out for IgG and IgM detection separately as well as for a combined analysis of both antibody classes. In total 662 samples of the MuSPAD study were analyzed. Number of positive and negative samples with both the commercial 2-step testing and the Borrelia multiplex are indicated. Percentage indicates Borrelia multiplex performance (sensitivity/specificity) compared to the commercial 2-step testing. 95% CI calculated by Wilson/Brown are shown. PPV—positive predictive value. NPV—negative predictive value.